EAM
FATE icon

Eagle Asset Management’s Fate Therapeutics FATE Stock Holding History

Eagle Asset Management’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-376,460
Closed -$3.83M – 553
2022
Q4 		$3.83M Buy
376,460
+8,023
+2% +$151K 0.02% 374
2022
Q3 		$8.26M Buy
368,437
+135,735
+58% +$3.92M 0.05% 262
2022
Q2 		$5.77M Buy
232,702
+5,126
+2% +$141K 0.04% 330
2022
Q1 		$8.82M Buy
227,576
+12,232
+6% +$474K 0.05% 293
2021
Q4 		$12.9M Sell
215,344
-43,792
-17% -$2.48M 0.06% 263
2021
Q3 		$15.4M Sell
259,136
-13,630
-5% -$1.07M 0.07% 244
2021
Q2 		$23.7M Sell
272,766
-14,529
-5% -$1.17M 0.1% 220
2021
Q1 		$23.5M Buy
+287,295
New +$27.5M 0.1% 226

Other funds holding FATE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return